StockClub

ALLO

ALLOAllogene Therapeutics, Inc.$ --
Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc.

ALLO

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
0M USD
YoY -
Operating Income
-42M USD
YoY +29.9%
Net Income
-39M USD
YoY +35.3%
EPS
-0.17$
YoY +39.3%

Revenue

$0
FY2024 Q1$22,000
$22,000
Q1
FY2024 Q2$22,000
$22,000
Q2
FY2024 Q3$22,000
$22,000
Q3
FY2024 Q4$22,000
$22,000
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
Actual
$-22,000 (-100.0%)

Net Income

$-190.9M
FY2024 Q1$-65M
$-65M
Q1
FY2024 Q2$-131.4M
$-131.4M
Q2
FY2024 Q3$-197.7M
$-197.7M
Q3
FY2024 Q4$-257.6M
$-257.6M
Q4
FY2025 Q1$-59.7M
$-59.7M
Q1
FY2025 Q2$-110.7M
$-110.7M
Q2
FY2025 Q3$-152.1M
$-152.1M
Q3
FY2025 Q4$-190.9M
$-190.9M
Q4
Actual
+$66.7M (+25.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$0
Est:$2.9M
FY2020MISS
$0
FY2021BEAT
Actual:$114.1M
Est:$38.3M
FY2021BEAT
$114.1M
FY2022MISS
Actual:$156,000
Est:$177,953
FY2022MISS
$156,000
FY2023BEAT
Actual:$95,000
Est:$65,000
FY2023BEAT
$95,000
FY2024MISS
Actual:$22,000
Est:$23,875
FY2024MISS
$22,000
FY2025MISS
Actual:$0
Est:$1,667
FY2025MISS
$0

Analyst Estimates